Assessment of the Effect of Atorvastatin on Prevention of CIN in Patients Undergoing Coronary Angiography
NCT ID: NCT02113540
Last Updated: 2014-04-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
INTERVENTIONAL
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Dose Atorvastatin for Preventing Contrast-induced Nephropathy
NCT02114346
Statins for Prevention of Contrast Induced Nephropathy
NCT00770796
Atorvastatin Effect on Contrast Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention
NCT04375787
The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease
NCT02133534
The Role of Statins in the Prevention of Contrast-induced Acute Kidney Injury in Patients With Cardiovascular Diseases
NCT04666389
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placebo group
taking atorvastatin like placebo 12 hours before the procedure
No interventions assigned to this group
long term statin group
taking atorvastatin for a long time before entering the study (their routine treatment)
No interventions assigned to this group
preoperation statin group
taking atorvastatin 12 hours before the procedure
Atorvastatin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Atorvastatin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* non-pregnant female subjects
* no history of diabetes mellitus
* no history of renal failure
* no history of single kidney
* no history of cardiogenic shock
* no history of unstable angina
* no history of myocardial infarction
* no history of hypersensitivity to statins
* no history of previous intravascular contrast injection during one month before admission
Exclusion Criteria
* cardiogenic shock
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Isfahan University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
peyman bidram
Dr peyman bidram
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Isfahan, Isfahan, Iran
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Grant number: 392172
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.